View Older Stories View More Recent Stories
-
Synthorx Announces $10 Million Series B Financing to Develop and Scale Novel Protein Therapeutics with Improved Pharmacological Properties
-
Unusual 11 Mid-Day Movers 7/15: (OPTT) (JCTCF) (ITI) Higher; (CYTR) (FMSA) (GBSN) Lower
-
Ardelyx (ARDX) Enters $110M Private Placement
-
Ardelyx to Raise $110 Million in a Private Placement
-
Bay Area Lyme Foundation Announces Finalists of "Lyme Innovation" Hackathon
-
Notable Mergers and Acquisitions 6/15: (EBIX)/(PN) (AEGR)/(QLTI) (DYN) (CBYL) (BBBY)
-
Carbylan Therapeutics (CBYL) Enters Merger Agreement with Privately-Held KalVista
-
Carbylan Therapeutics, Inc. and KalVista Pharmaceuticals Ltd. Enter into Share Purchase Agreement
-
Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, LLC
-
Antera Raises $1.7M to Help Infants At Risk of Developing Food Allergies
-
KalVista Pharmaceuticals to Support Global Conference Focused on Hereditary Angioedema
-
Peregrine Communications Expands US Footprint with Suite of New Clients, Key Business Advisors and the Appointment of a New Senior Hire to Bolster Growth
-
Form 13F-HR RA CAPITAL MANAGEMENT, For: Mar 31
-
Kala Pharmaceuticals Announces Closing of $68 Million Series C Financing
-
Eiger BioPharmaceuticals Closes Merger With Celladon
-
Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31
-
Form SC 13G/A VICAL INC Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Xencor Inc Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ACADIA PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A SCYNEXIS INC Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Arbutus Biopharma Corp Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A AGILE THERAPEUTICS INC Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A DYNAVAX TECHNOLOGIES Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A TREVENA INC Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Aclaris Therapeutics, Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Cidara Therapeutics, Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A BIOCRYST PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A WaferGen Bio-systems, Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Aurinia Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Blueprint Medicines Corp Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A COLLEGIUM PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ARDELYX, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A AmpliPhi Biosciences Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A PROTEON THERAPEUTICS Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ZOGENIX, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A TENAX THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Zynerba Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A TG THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Regulus Therapeutics Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G Axovant Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A AQUINOX PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ARCA biopharma, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G DERMA SCIENCES, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form 4 Aclaris Therapeutics, For: Jan 15 Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form 4 Aclaris Therapeutics, For: Jan 11 Filed by: RA CAPITAL MANAGEMENT, LLC
-
PlacementTracker Publishes 2015 PIPE Market League Tables
-
Form SC 13D Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Notable Mergers and Acquisitions 11/19: (PFE)/(AGN) (VHI) (TDG)/(BZC) (CC)/(DOW)

